Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study
暂无分享,去创建一个
P. Smolak | R. Levin | R. Martin | D. Burge | S. Cohen | J. Eisenman | K. Byrnes-Blake | K. Lau | A. Kivitz | Y. Sherrer | J. Posada | S. Cohen | Daniel Burge | Kelly Byrnes-Blake | Alan J. Kivitz | Richard W. Martin | James A. Posada